Ventyx Biosciences logo

Ventyx Biosciences

VTYX | NASDAQ
Chart Builder DCF Calculator
$14.00
$0.00 (0.00%)
At close: Mar 3, 2026, 4:00 PM ET
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Sep 30, 2026
26.2
+11.7 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $1B
1D Range
14.00 14.00
52W Range
0.78 25.00

Valuation (TTM)

PE -9.33
PB 5.25
EV/EBITDA -7.79

Valuation (NTM)

Forward PE N/A
Forward PEG -0.98
Price Target $26.78
Loading financial charts...

Profile

Ventyx Biosciences, Inc. is a biopharmaceutical company in the clinical development phase, specializing in the creation of small molecule therapeutics for inflammatory and autoimmune disorders. The co...

Sector Healthcare
Industry Biotechnology
Employees 81
IPO Date Oct 21, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
6
Consensus
Hold
Price Target
$14.00
Upside
0.00%
Buy (0)
Hold (5)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.